Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "DexCom Inc (DXCM) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. This analytical report serves as a ...

Shares of DexCom, Inc. ( DXCM) closed at a new 52-week high of $53.50 on Nov 10, translating into a solid one-year return of roughly 62%. In fact, shares of this CA-based glucose monitoring systems ...

DexCom projects 2025 revenue of $4.6 billion, representing 14% growth. This forecast assumes strong demand for CGM systems, expanded reimbursement coverage, and a second-half launch of a 15-day G7 ...

Coming off what it’s described as its “best year ever,” the continuous glucose monitoring provider Dexcom is now looking to expand its work among people with Type 2 diabetes in a new, wider ...

Dexcom DXCM announced its strategy to expand the accessibility of its glucose sensing technology products to millions of other patients than currently covered. Its plan includes expansion in ...

Enter long short position between 74.21 (the lower band of its horizontal resistance zone) and 75.94 (the upper band of its horizontal resistance zone).Market Index Analysis DexCom (DXCM) is a member ...

For two months now, Alex Donnelly has been trying to get a high-tech medical device that will help him with his diabetes. Donnelly had used that very product, called a continuous glucose monitor (CGM) ...

Kevin Sayer, CEO, highlighted that Q4 2024 organic revenue growth was 8%, contributing to a full-year organic growth of 12%, aligned with guidance. The company ended 2024 with over 2.8 million global ...